Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2013 2
2014 2
2015 3
2016 1
2017 3
2018 1
2019 2
2020 1
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence.
Hach T, Shakeri-Nejad K, Bigaud M, Dahlke F, de Micco M, Petricoul O, Graham G, Piani-Meier D, Turrini R, Brinkmann V, Nicoletti F. Hach T, et al. Among authors: shakeri nejad k. J Interferon Cytokine Res. 2023 Jun;43(6):246-256. doi: 10.1089/jir.2022.0078. Epub 2022 Nov 29. J Interferon Cytokine Res. 2023. PMID: 36454249 Free PMC article. Review.
Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data.
Schoedel KA, Kolly C, Gardin A, Neelakantham S, Shakeri-Nejad K. Schoedel KA, et al. Among authors: shakeri nejad k. Psychopharmacology (Berl). 2022 Jan;239(1):1-13. doi: 10.1007/s00213-021-06011-6. Epub 2021 Nov 13. Psychopharmacology (Berl). 2022. PMID: 34773483 Free PMC article. Review.
Effects of triclabendazole and its metabolite exposure on the heart-rate-corrected QT intervals: A randomized, placebo- and positive-controlled thorough QT study in healthy individuals.
Prince WT, Venishetty VK, Lecot J, Shakeri-Nejad K, Gray C, Taylor A, Iyer GR, Zack J. Prince WT, et al. Among authors: shakeri nejad k. Clin Transl Sci. 2023 Oct;16(10):1758-1767. doi: 10.1111/cts.13564. Epub 2023 Sep 8. Clin Transl Sci. 2023. PMID: 37688315 Free PMC article. Clinical Trial.
Impact of siponimod on vaccination response in a randomized, placebo-controlled study.
Ufer M, Shakeri-Nejad K, Gardin A, Su Z, Paule I, Marbury TC, Legangneux E. Ufer M, et al. Among authors: shakeri nejad k. Neurol Neuroimmunol Neuroinflamm. 2017 Sep 13;4(6):e398. doi: 10.1212/NXI.0000000000000398. eCollection 2017 Nov. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28955715 Free PMC article.
Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers.
Sangana R, Xu Y, Shah B, Tian X, Zack J, Shakeri-Nejad K, Kalluri S, Jones I, Ligueros-Saylan M, Taylor AF, Jain DK, Scosyrev E, Uddin A, Laurent N, Paganoni P. Sangana R, et al. Among authors: shakeri nejad k. Clin Pharmacol Drug Dev. 2024 Feb 22. doi: 10.1002/cpdd.1373. Online ahead of print. Clin Pharmacol Drug Dev. 2024. PMID: 38389387
20 results